Search Within

Jose T Baselga

  1. "Cancer Biology and Genetics Program Faculty"
Formats
  1. Journal Article (3)
  2. Meeting Abstract (2)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (5)
  2. Cancer Biology and Genetics Program Faculty (5)
  3. Center for Hematologic Malignancies (5)
  4. Center for Molecular Imaging and Biotechnology (CMIB) (5)
  5. Center for Pancreatic Cancer Research (5)
  6. Executive Committee, Center for Hematologic Malignancies (5)

More Groups

People
  1. Maurizio Scaltriti (4)
  2. Saya Ebbesen (4)
  3. Scott Lowe (4)
  4. David Solit (3)
  5. Haley Ellis (3)
  6. Helen Won (3)

More People

Years
  1. 2017 (1)
  2. 2016 (1)
  3. 2015 (1)
  4. 2014 (2)
Publications
  1. Cancer Research (1)
  2. European Journal of Cancer (1)
  3. JCI Insight (1)
  4. Nature (1)
  5. Proceedings of the National Academy of Sciences of the United States of America (1)
Publishers
  1. Amer Soc Clinical Investigation Inc (1)
  2. American Association for Cancer Research (1)
  3. Elsevier Inc. (1)
  4. National Academy of Sciences (1)
  5. Nature Publishing Group (1)

Results (5)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Panobinostat acts synergistically with ibrutinib in diffuse large B cell lymphoma cells with MyD88 L265 mutations
    Journal Article

    Mondello, P.; Brea, E. J.; De Stanchina, E.; Toska, E.; Chang, A. Y.; Fennell, M.; Seshan, V.; Garippa, R.; Scheinberg, D. A.; Baselga, J.; more...
    JCI Insight (2017)

    Fulltext@MSK | Save
  • Pten loss promotes MAPK pathway dependency in HER2/neu breast carcinomas
    Journal Article

    Ebbesen, S. H.; Scaltriti, M.; Bialucha, C. U.; Morse, N.; Kastenhuber, E. R.; Wen, H. Y.; Dow, L. E.; Baselga, J.; Lowe, S. W.
    Proceedings of the National Academy of Sciences of the United States of America (2016)

    Fulltext@MSK | Save
  • Convergent loss of PTEN leads to clinical resistance to a PI(3)Kα inhibitor
    Journal Article

    Juric, D.; Castel, P.; Griffith, M.; Griffith, O. L.; Won, H. H.; Ellis, H.; Ebbesen, S. H.; Ainscough, B. J.; Ramu, A.; Iyer, G.; more...
    Nature (2015)

    Fulltext@MSK | Save
  • Loss of PTEN leads to clinical resistance to the PI3K alpha inhibitor BYL719 and provides evidence of convergent evolution under selective therapeutic pressure
    Meeting Abstract

    Castel, P.; Juric, D.; Won, H.; Ainscough, B.; Ellis, H.; Ebbesen, S.; Griffith, M.; Griffith, O.; Iyer, G.; Sgroi, D.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Loss of PTEN leads to acquired resistance to the PI3Ka inhibitor BYL719: A case of convergent evolution under selective therapeutic pressure
    Meeting Abstract

    Castel, P.; Juric, D.; Griffith, M.; Griffith, O. L.; Won, H. H.; Ainscough, B.; Ellis, H.; Ebbesen, S.; Gopakumar, I.; Quadt, C.; more...
    European Journal of Cancer (2014)

    Fulltext@MSK | Save